[Efficacy of combined antiviral therapy with pegylated interferon alpha-2a and ribavirin for chronic hepatitis C infection in intravenous drug users].

Abstract

INTRODUCTION Hepatitis C Virus infection represents not just a medical, but also a socio-economic problem. It is estimated that among 170 million infected, 60% belongs to the category of intravenous drug users (IDUs). OBJECTIVE The aim of this paper was to compare the response to the combined therapy of pegylated interferon alfa 2a and ribavirin, in the… (More)

Topics

Cite this paper

@article{Rui2010EfficacyOC, title={[Efficacy of combined antiviral therapy with pegylated interferon alpha-2a and ribavirin for chronic hepatitis C infection in intravenous drug users].}, author={Maja Ru{\vz}i{\'c} and Fabri Milotka and Biljana Klasnja and Marta Pobor and Daniela Svarc and Aleksandra S Jovelic and Izabella Fabri}, journal={Srpski arhiv za celokupno lekarstvo}, year={2010}, volume={138 1-2}, pages={43-9} }